Clanobutin sodium is an appetite stimulant (a choleretic drug) used for treating digestive upsets in animals.
Clanobutin Sodium Review
Status: review completed
In 1997 the APVMA (formerly the NRA) began a review of clanobutin sodium following concerns expressed by the Therapeutic Goods Administration (TGA) about the potential risk to the public from long-term exposure to its residues in food.
In May 1999 the APVMA completed the review of clanobutin sodium but no final report was released. The APVMA found that the risk of long term exposure to humans was very low and the continued registration of this product on toxicological grounds was supported. However, there were insufficient data to support the existing withholding periods for clanobutin sodium. The APVMA recommended increasing the withholding periods for meat and milk. Read a full history of the review.
|No report available|
For more information contact:
Phone: +61 2 6210 4749
Fax: +61 2 6210 4776
Search the PUBCRIS database for registered products that contain clanobutin sodium.
Note: In the Active Constituent 1 field enter clanobutin sodium.
APVMA Clanobutin Sodium Archive